HCC patients suffer less from geographic differences in organ availability.
1Department of Surgery, Division of Transplantation, Massachusetts General Hospital, Boston, MA.
Summary
The Model for End-Stage Liver Disease (MELD) exception points for hepatocellular carcinoma (HCC) may overestimate mortality risk. HCC patients face lower waitlist mortality compared to non-HCC patients, especially with increased organ competition.
Area of Science:
- Hepatology
- Transplant Surgery
- Biostatistics
Background:
- The Model for End-Stage Liver Disease (MELD) exception points for hepatocellular carcinoma (HCC) may overestimate patient mortality risk.
- Organ availability, measured by average MELD at transplant, varies by donation service area (DSA) and impacts transplant outcomes.
- Understanding differential impacts of DSA organ availability on HCC and non-HCC patients is crucial for equitable organ allocation.
Purpose of the Study:
- To compare transplant and death parameters between HCC patients with exception points and non-HCC patients.
- To determine if HCC and non-HCC groups are differentially affected by DSA organ availability.
- To assess the accuracy of MELD exception points in reflecting actual mortality risk.
Main Methods:
- Analysis of Scientific Registry of Transplant Recipients data from 2005 to 2010.
- Comparison of transplant rates and waitlist mortality between HCC and non-HCC patient cohorts.
- Statistical analysis of the relationship between MELD scores, DSA, and mortality risk pre- and post-transplant.
Main Results:
- HCC candidates exhibit higher transplant rates and lower waitlist mortality than non-HCC candidates.
- Waitlist mortality risk decreases for HCC patients with increasing MELD points (not statistically significant), but increases significantly for non-HCC patients.
- Post-transplant mortality risk decreases with MELD points for HCC patients (not statistically significant) but increases for non-HCC patients, with significant differences between groups.
Conclusions:
- Increasing wait time disproportionately affects non-HCC candidates compared to HCC candidates.
- The MELD exception system may confer an advantage to HCC patients, particularly under conditions of high organ competition.
- Further research is needed to refine MELD scoring to ensure equitable organ allocation.
Keywords:
Hepatocellular carcinomaMELD scoredonation service arealiver transplantationorgan allocationMore Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
